Cargando…
Targeting on the NAD(+)‐mitophagy axis to treat cardiovascular disease
Autores principales: | Fang, Evandro F., Tao, Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7574632/ https://www.ncbi.nlm.nih.gov/pubmed/33103034 http://dx.doi.org/10.1002/agm2.12123 |
Ejemplares similares
-
Turning up the NAD(+)-mitophagy axis to treat Alzheimer’s disease
por: Fang, Evandro F., et al.
Publicado: (2022) -
Mitophagy and NAD(+) inhibit Alzheimer disease
por: Fang, Evandro F.
Publicado: (2019) -
NAD(+) augmentation restores mitophagy and limits accelerated aging in Werner syndrome
por: Fang, Evandro F., et al.
Publicado: (2019) -
CD38-NAD(+)-Sirt1 axis in T cell immunotherapy
por: Chatterjee, Shilpak, et al.
Publicado: (2019) -
Editorial: Mitophagy in Health and Disease
por: Palikaras, Konstantinos, et al.
Publicado: (2021)